Related references
Note: Only part of the references are listed.Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data
Lucy A. McNamara et al.
LANCET (2022)
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
Hung Fu Tseng et al.
NATURE MEDICINE (2022)
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
David W. Eyre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021
Amelia G. Johnson et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022
Anastasia S. Lambrou et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)
Sean Wei Xiang Ong et al.
CLINICAL INFECTIOUS DISEASES (2022)
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study
Eric J. Haas et al.
LANCET INFECTIOUS DISEASES (2022)
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Katherine A. Twohig et al.
LANCET INFECTIOUS DISEASES (2022)
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Adam S. Lauring et al.
BMJ-BRITISH MEDICAL JOURNAL (2022)
County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis
John M. McLaughlin et al.
LANCET REGIONAL HEALTH-AMERICAS (2022)
Coronavirus Disease Case Definitions, Diagnostic Testing Criteria, and Surveillance in 25 Countries with Highest Reported Case Counts
Amitabh B. Suthar et al.
EMERGING INFECTIOUS DISEASES (2022)
SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities
Rochelle P. Walensky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
Eric J. Haas et al.
LANCET (2021)
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
Victoria Jane Hall et al.
LANCET (2021)
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel-33 US Sites, January-March 2021
Tamara Pilishvili et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Impacts of social distancing policies on mobility and COVID-19 case growth in the US
Gregory A. Wellenius et al.
NATURE COMMUNICATIONS (2021)
Temporal trends in the association of social vulnerability and race/ethnicity with county-level COVID-19 incidence and outcomes in the USA: an ecological analysis
Shabatun J. Islam et al.
BMJ OPEN (2021)
Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage
Athalia Christie et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021
Ashley Fowlkes et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021
Heather M. Scobie et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021
Eli S. Rosenberg et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020–May 2021
Prabasaj Paul et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
Wesley H. Self et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
Andrew T. Levin et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)